Andy Harrison is the Strategic Business Development Lead at Verily Life Sciences, the healthcare commercialization arm of Alphabet Inc. At Verily, Andy focuses on partnerships, collaborations, corporate ventures, and acquisitions. His passion is for bringing new technologies to market. He started his career at RBC Ventures and Celtic House Venture Partners. He was also a partner at a venture-backed investment firm that spun out of Stanford University’s endowment. The firm scaled up and was successfully acquired by a Wall Street firm. Andy has degrees in biochemical and biomedical engineering from McGill and Cornell. He serves and has served actively on a number of domestic and international boards.